1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
United Orthopedic Corporation

United Orthopedic Corporation

TTPEX:4129
77.00
TWD
+0.90
(+1.18%)
5.51EPS
16.04P/E
8.84BMarket Cap
Nov 11Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.4
20.01
23.37
19.45
26.99
29.37
30.57
29.9
33.02
40.57
46.61
48.42
58.64
62.89
Basic EPS, GAAP
0.39
1.49
2.25
2.06
1.78
1.61
1.11
1.3
0.67
2.84
4.56
4.75
5.83
5.72
Free Cash Flow per Basic Share
-3.76
-1.62
0.74
-2.98
-7.7
-4.52
2.82
3.43
1.48
-0.38
-1.47
1.33
2.74
-0.91
Dividend per Share
0.39
0.45
1.14
1.61
1.36
1.26
2.02
0.88
1.14
- -
2.38
4.02
4
- -
Book Value per Share
14.98
16.96
24.33
24.15
27.66
28
33.91
33.81
33.57
36.93
39.82
39.95
42.51
40.47
Tangible Book Value per Share
14.51
16.61
24.12
23.63
22.2
22.08
27.69
27.26
26.93
29.62
33.31
33.96
36.3
34.33
Basic Weighted Avg Shares
55
55
60
71
73
79
80
78
78
78
84
96
96
96
Sales/Revenue/Turnover
956
1,101
1,393
1,383
1,973
2,332
2,437
2,342
2,571
3,169
3,930
4,653
5,655
6,067
Operating Margin (%)
2.18
9.22
12.87
11.54
8.21
3.5
3.38
3.84
6.22
11.01
13.66
13.41
13.03
11.31
Depreciation Expense
86
107
124
104
150
215
270
287
310
335
396
460
539
597
Net Income, GAAP
21
82
134
147
130
128
89
102
52
222
384
456
562
552
Effective Tax Rate (%)
42.11
24.91
19.28
11.25
33.03
4.61
20.89
7.19
29.11
26.22
23.75
19.95
24.45
24.17
Profit Margin (%)
2.23
7.42
9.61
10.6
6.6
5.47
3.64
4.35
2.03
6.99
9.78
9.81
9.95
9.09
Working Capital
528
401
1,225
661
671
781
1,051
940
490
905
1,493
1,352
1,790
1,416
LT Debt
397
192
148
156
614
885
945
882
405
711
856
515
1,002
1,100
Total Equity
851
1,011
1,773
1,802
2,218
2,250
2,934
2,925
2,821
3,090
3,594
3,950
4,204
4,005
Return on Invested Capital (%)
0.96
4.92
7.8
6.22
3.54
2.06
1.46
1.76
2.42
5.52
8.24
8.7
9.08
8.87
Return on Capital (%)
2.15
5.9
7.82
7.03
5.24
4.56
3.01
2.8
1.37
5.15
8.37
8.82
9.74
9.98
Return on Common Equity (%)
2.91
8.78
9.61
8.27
6.55
5.75
3.57
3.74
1.96
8.03
12.03
12.43
14.15
14.54

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,058
1,158
1,261
LT Borrowings
813
792
772
LT Finance Leases
189
323
328
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
96
96
96
Market Capitalization
10,801
9,432
8,843

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
4,290
4,508
4,711
Cash, Cash Equivalents & STI
663
643
580
Accounts Receivable, Net
1,302
1,398
1,438
Inventories
2,074
2,226
2,410
Total Current Liabilities
2,500
2,723
3,295
Payables & Accruals
- -
- -
- -
ST Debt
1,058
1,158
1,261
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.49%
7.73%
6.44%
Free Cash Flow
-55.41%
8.43%
106.79%
Net Income, GAAP
37.14%
78.12%
23.24%
Sales/Revenue/Turnover
15.77%
19.39%
21.54%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,066
1,141
1,131
1,316
4,653
2025
1,297
1,351
1,492
1,516
5,655
2026
1,494
1,565
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.98
1.06
1.44
1.27
4.75
2025
1.98
0.48
2.01
1.36
5.83
2026
0.91
1.44
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.02
2025
- -
- -
- -
- -
4
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yan Sheng Lin
Full Time Employees
576
Sector
Health technology
Industry
Medical specialties
Address
No.80, Sec.1, Chenggong Rd. Hsinchu Taiwan 234634
IPO Date
Jan 23, 2003
Website
unitedorthopedic.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
United Orthopedic Corporation engages in the design, development, production, and global distribution of advanced orthopedic implant solutions and their corresponding surgical instrumentation. The enterprise provides an extensive selection of hip replacement systems, including options for primary procedures, complex revisions, limb salvage, and custom implants for oncology patients. Its offerings extend to a broad range of knee systems, featuring both primary and revision knee replacement devices tailored to diverse surgical requirements. Additionally, the company supplies trauma and internal fixation products such as bone plates, nails, pins, and screws. It supports healthcare providers with vital clinical education and dedicated customer service. Operating with a vertically integrated manufacturing process, United Orthopedic ensures stringent quality control and efficient responsiveness in bringing its innovative products to market. Founded in 1993 and based in New Taipei City, Taiwan, the company maintains a significant international footprint, serving over 52 countries across Asia, the Americas, Europe, Africa, and Australia through its network of nine global branch offices. Demonstrating sustained expansion, the firm recently achieved record-high revenues in the first quarter of 2025. Its clinically proven products have facilitated over 770,000 surgeries, underscoring its commitment to enhancing patient outcomes worldwide.